Five practical steps to address the global problem of antibiotic drug resistance have been outlined in a new paper published as part of the O'Neill Review, which was commissioned by UK Prime Minister David Cameron to come up with solutions.
Five practical steps to address the global problem of antibiotic drug resistance have been outlined in a new paper published as part of the O'Neill Review, which was commissioned by UK Prime Minister David Cameron to come up with solutions.
The review, headed by economist and former head of Goldman Sachs Asset Management Jim O'Neill, has identified where action can...
Glenmark’s managing director talks about IGI’s billion dollar-plus deal with AbbVie, ISB-2001’s striking data, the BEAT platform, other "exciting" pipeline assets and the "blood, sweat and tears" to get to this stage.
Four Chinese companies have won approvals in China, the first anywhere, for novel drugs for diffuse large B-cell lymphoma, certain types of non-small cell lung cancer and influenza A.
IGI CEO Cyril Konto said in an interview that his company picked AbbVie for its agility, drug development acumen and expertise in areas like intellectual property and legal affairs.
The Swiss company believes its platform can make radiopharmaceuticals easier to produce and more accessible to patients.
IGI CEO Cyril Konto said in an interview that his company picked AbbVie for its agility, drug development acumen and expertise in areas like intellectual property and legal affairs.
The osteogenesis imperfecta drug stumbled in a second interim analysis.
The Swiss company believes its platform can make radiopharmaceuticals easier to produce and more accessible to patients.
